ALLO
Allogene Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.97
−0.51%Leverage
- Debt / equity
- 0.16x
- Net debt / equity
- 0.07x
- Debt / assets
- 0.13x
- Debt / EBITDA
- -0.46x
- Net debt / EBITDA
- -0.21x
Liquidity & coverage
- Current ratio
- 10.72x
- Quick ratio
- 10.72x
- Cash ratio
- 10.48x
- Interest coverage
- -138.71x
- EBITDA / interest
- -117.33x
- Working capital
- $308.3M
Cash & dividend
- FCF / debt
- -1.46x
- Cash flow / debt
- -1.45x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026